Glooko and Fit4D are combining their offerings to provide patients with an “end-to-end” solution for diabetes management.
Intuitive Surgical has bagged a CE mark for the latest product in its da Vinci series of robot-assisted surgical systems.
It’s a critical tradeoff for life. Our bodies use sugar and fat from the food we consume to produce energy in our cells’ mitochondria, the internal powerhouses…
MAP Health Management and Lief Therapeutics are tying up to monitor patients with substance use disorder.
The FDA granted Allergan marketing authorization for its intranasal tear stimulator, which temporarily increases tear production in adult patients.
Two Pore Guys closed a $24.5 million Series A round, which will boost the manufacturing of the company’s handheld testing system.
Johns Hopkins spinout Sonavex reeled in $3 million, including $2.2 million from the first close of its Series A round for its ultrasound blood-clot detector.
Private equity giant KKR is reportedly in “advanced” discussions to acquire a stake in New Delhi-based SRL Diagnostics, a deal potentially worth $775 million.
HTG Molecular Diagnostics is teaming up with Spain’s Instituto Valenciano de Oncología to develop a score to predict breast cancer recurrence.
BD has struck a $24 billion deal to buy C.R. Bard to strengthen its position in the markets for catheters, pumps and other items.
IBM developed a method combining deep learning and visual analytics to detect and gauge the severity of diabetic retinopathy from an eye image.